[Latest] Global Badminton Racket Market Size/Share Worth USD 1.86 Billion by 2034 at a 6.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) [220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Badminton Racket Market size […]

Gaming Stars Unite to Level Up Support for Children's Miracle Network Hospitals Extra Life, a fundraising program of Children's Miracle Network Hospitals, is proud to join forces with State Farm for Season 4 of Gamerhood, the award-winning reality competition bringing together top-tier gamers, streamers, and entertainers for a good cause. This dynamic collaboration will raise

The Italian wine industry demonstrates its commitment to the US with Vinitaly.USA's return; event features Wine2Wine and Wine Spectator's anticipated OperaWine reveal; highlights the vital partnership between Italian and American wine businesses Italy strengthens its historic and long-standing partnership with the US market at a pivotal time for the wine industry, with Vinitaly.USA 2025, returning

NEW YORK, NY / ACCESS Newswire / July 28, 2025 / If you suffered a loss on your Fortrea Holdings Inc. (NASDAQ:FTRE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortrea-holdings-inc-lawsuit-submission-form?prid=158521&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Top Restructuring Firms Collaborate to Tackle Most Complex and Challenging Assignments MACCO Restructuring Group, an award-winning, Houston-based national business restructuring and financial advisory firm, today announced a formal strategic alliance with the Algon Group, a leading boutique financial advisory and restructuring firm for complex and bet-the-company matters based in Miami, Florida. https://mma.prnewswire.com/media/2925/algon_group_logo_2927_21088_.jpg This alliance underscores

Expanding to a purpose-built facility designed to better support students with autism and behavioral needs in Indiana County – Open House and Ribbon Cutting scheduled for July 30 New Story Schools is excited to announce plans to relocate its Indiana, Pennsylvania campus to a newly renovated, purpose-built facility in Blairsville for the 2025-2026 school year.

Qynapse, a technology company using AI to enhance the quantification and predictive capabilities of imaging to improve outcomes for neurological diseases, including Alzheimer's disease (AD), presented new data at the Alzheimer's Association International Conference (AAIC) for QyScore® and QyPredict®. https://mma.prnewswire.com/media/2739368/QYNAPSE_Logo.jpg QyScore® is an FDA-cleared and CE-marked proprietary neuroimaging software platform that enables fully automated, high-resolution

The 12-week Authentic Self-Empowerment Framework offers a proven, structured method for introverted professional women to overcome internal stress, rediscover their purpose Wake Up Talks Coaching, founded by accredited coach and former business strategistSimona Zajc, has officially launched the Authentic Self-Empowerment Pathway, a private, 12-week coaching experience specifically designed to support introverted professional women in midlife

Next-Gen Batteries Set for 28.5% CAGR Through 2029 “Comprehensive Market Analysis Highlights Opportunities and Challenges in the Evolving Next-Gen Battery Sector for EVs and Energy Storage” GlobeNewswire July 28, 2025 Boston, July 28, 2025 (GLOBE NEWSWIRE) — According to the latest study from BCC Research, “Next-Generation Advanced Batteries: Global Markets” is projected to grow from

NEW YORK, NY / ACCESS Newswire / July 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Replimune Group, Inc. ("Replimune Group, Inc.") (NASDAQ:REPL) concerning possible violations of federal securities laws. On July 22, 2025, Replimune announced that it received a Complete Response Letter from the FDA rejecting its